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Abstract
The human intestinal parasite Schistosoma mansoni causes a chronic disease, schistosomiasis or bilharzia. According to the
current literature, the parasite induces vigorous immune responses that are controlled by Th2 helper cells at the expense of
Th1 helper cells. The latter cell type is, however, indispensable for anti-viral immune responses. Remarkably, there is no
reliable literature among 230 million patients worldwide describing defective anti-viral immune responses in the upper
respiratory tract, for instance against influenza A virus or against respiratory syncitial virus (RSV). We therefore re-examined
the immune response to a human isolate of S. mansoni and challenged mice in the chronic phase of schistosomiasis with
influenza A virus, or with pneumonia virus of mice (PVM), a mouse virus to model RSV infections. We found that mice with
chronic schistosomiasis had significant, systemic immune responses induced by Th1, Th2, and Th17 helper cells. High serum
levels of TNF-a, IFN-c, IL-5, IL-13, IL-2, IL-17, and GM-CSF were found after mating and oviposition. The lungs of diseased
mice showed low-grade inflammation, with goblet cell hyperplasia and excessive mucus secretion, which was alleviated by
treatment with an anti-TNF-a agent (Etanercept). Mice with chronic schistosomiasis were to a relative, but significant extent
protected from a secondary viral respiratory challenge. The protection correlated with the onset of oviposition and TNF-a-
mediated goblet cell hyperplasia and mucus secretion, suggesting that these mechanisms are involved in enhanced
immune protection to respiratory viruses during chronic murine schistosomiasis. Indeed, also in a model of allergic airway
inflammation mice were protected from a viral respiratory challenge with PVM.
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Introduction
Immunity to intracellular pathogens like viruses and mycobac-
teria is ensured by type I immune responses. These responses are
dependent on and characterised by IFN-c [1]. In contrast,
infestation with helminths, including that by the parasitic
trematode worms of the genus Schistosoma, typically elicits host
type-II immune responses that are characterised by a massive
production of the cytokines IL-4, IL-5 and IL-13 [2,3]. These
cytokines are thought to inhibit the induction of type I immune
responses [1,3,4]. Helminthic infections are moreover often
brought in context with a generalised immune regulation or
suppression. Improved hygienic conditions, in which helminth
infections have become rare, are now often implied in diseases that
are caused by unbalanced immune system activity, like autoim-
mune diseases and allergy. This is subsumised in the hygiene
hypothesis [5]. In this passed-on framework of mutually exclusive
immune response types and generalised immunosuppression in
worm infestation, anti-viral and anti-mycobacterial responses
should be severely hampered in areas with a high spread of
Schistosoma parasites. However, an unambiguous disease pattern
was not found [6,7].
Schistosomiasis or bilharzia is a chronic and, when untreated,
finally lethal parasitic disease; approximately 230 million people
worldwide require treatment yearly [8]. Murine schistosomiasis
caused by S. mansoni resembles human schistosomiasis in many,
but not all respects [9]. The pathogenesis involves a passage of the
helminth through several organ systems and elicits several types of
immune defence mechanisms. An initial Th1-biased host immune
response is induced by the invasion of the infectious cercariae. The
immature worms (schistosomula) travel through the lungs and liver
to their final destination in the portal veins, where they mate.
Around 6 weeks after entry, egg deposition by the worm pairs
starts. The Th1-biased immune response converts into a Th2-
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biased response, and is accompanied by a regulatory (suppressive)
response with the production of the prototypical cytokine IL-10
[10]. Eggs must travel through the walls of vessel and gut to reach
the gut lumen and to leave the host to continue their life cycle. The
passage through the gut wall affects its integrity, requiring repair
mechanisms and an increased anti-bacterial response, and is
accompanied by extensive inflammation. Repair mechanisms are
induced by IL-4 and IL-13 [11], whereas defence to extracellular
bacteria is dependent on Th17 responses with the signature
cytokine IL-17 [12]. Not all eggs make it to the gut lumen. Many
are flushed into the liver or are stuck in the gut wall, where they
are then encapsulated by a fibrotic granulomatous response.
Coinfection studies in animal models which could have shed
light on the anomalous comorbidity situation were also not
conclusive and often difficult to interpret: hepatotropic viruses like
HCV and LCMV target an organ, which is stressed by the
granulomatous reaction and which is extremely sensitive to
cytopathologic effects of TNF-a and IL-12 [13–15].
The lack of expected comorbidities and the ambiguous animal
coinfection studies are puzzling in the light of the predominant
immunological dogmas. More study is required, with emphasis on
systemic effects. The observations also raise the question, whether,
from an evolutionary point of view, the parasitic relationship does
not only have an unfavourable, but also a certain beneficial effect
on the host [16]. Further, recent evidence points to the (gut)
microbiome as a modulator of immune responses, also in distant
locations like the airways, to respiratory viruses [17,18].
In the present study we infected mice, without antibiotic
treatment, with a human isolate of S. mansoni from Oman. We
tested the immune response in the chronic phase of the disease, to
viruses with tropism for tissues that are not directly targeted in
schistosomiasis. Hereto we have chosen the respiratory tract
viruses pneumonia virus of mice (PVM) [19] and influenza A [20].
We show that a primary, chronic infection with the Omani isolate
induces strong, coexistent, and systemic cytokine secretion of the
Th1, Th2, and Th17 type. In particular, high serum levels of
TNF-a were found that induced a low-grade inflammatory
response and a marked hyperplasia of mucus-producing cells in
the lung. Under these conditions, mice were relatively well
protected from a secondary infectious challenge with the
pneumotropic viruses influenza A and PVM. This suggests that
chronic schistosomiasis can provide a beneficial effect on the host
by reducing the susceptibility to respiratory viral infections.
Materials and Methods
Ethics Statement
Animal experimentation was approved by the local animal
welfare authority (Regierungspra¨sidium Freiburg, Abt. 3, Referat
35; reference: AZ.: 35/9185.81/G-08/104), based on local law
and animal ethics regulations (Tierschutzgesetz: http://www.
gesetze-im-internet.de/bundesrecht/tierschg/gesamt.pdf). The
health status of the mice was scored with some modifications
according to Morton and Griffiths [21]. Criteria used for
termination were: appearance (grooming, starey coat, posture,
dehydration, crusty eyes or nose); body weight (slight (,5%),
moderate (5–10%), moderate with decreased appetite (10–20%),
severe (.20%); clinical symptoms (breathing rate, heart rate, body
temperature, diarhoea, anaemia); handling (alertness, agressive-
ness, irritability); and behaviour (self-mutilation). Animal condition
was monitored on a daily basis, if necessary, at shorter intervals.
Mice were sacrificed by asphyxia in carbondioxide.
Mice
Mice were bred and kept in the SPF animal facility of the Max-
Planck-Institute of Immunobiology and Epigenetics or of the
Virology Department of the University of Freiburg, without
antibiotic treatment. B6.A2G-Mx1 mice carrying functional Mx1
alleles were previously described [20].
Infections
S. mansoni. An Omani human isolate [22] was maintained
using Biomphalaria species as intermediate hosts. Mice were
anaesthetized with Ketamine/Xylazine (0.1 mg resp. 0.5 mg/
mouse) and exposed to 80–90 cercariae via the shaved belly
method [23]. Infection efficiency was ,75% (number of cercariae
left after 1 h of exposure/number of input cercariae). Mice were
infected at 10–11 weeks of age.
Influenza. Mice were anaesthetized with Ketamine/Xylazine
and infected intranasally (i.n.) with either influenza A strain hvPR8
or strain PR8. For influenza A strain hvPR8 (a highly virulent
variant of A/PR/8/34 [20]) Mx1-competent mice received 60 or
200 pfu in 50 ml MEM. Mx1-competent control mice received
56105 U hybrid human IFN-aB/D one day before virus
challenge. For influenza A strain PR8 C57BL/6J mice (Mx1-
deficient) received 2000 pfu i.n. in 50 ml MEM. Challenge was at
10–12 weeks after primary infection with S. mansoni. Control
mice were left untreated until the infection with influenza virus.
PVM. Mice were anaesthetized with isoflurane (Baxter) and
infected i.n. with either 200 or 2000 pfu of PVM clone 15 (ATCC)
in 80 ml MEM medium. Virus titers were determined as described
previously [24]. Viral challenge was at 12 weeks after primary
infection with S. mansoni, unless stated otherwise. Control mice
were infected at 12–15 weeks of age.
After infection, mice were observed daily and weighed at
indicated time points at the same time of day.
Treatment with Etanercept
Mice received Etanercept (a kind gift of Pfizer Germany) at
4 mg/kg body weight intraperitoneally at the indicated time
points.
Immunisation with OVA
Mice were immunised i.p. with 20 mg chicken egg ovalbumin
(OVA; grade V; Sigma-Aldrich) in 200 ml Alum (4 mg/ml in PBS;
Imject Alum Adjuvant; ThermoScientific), at day 0, 7 and 14.
Two weeks later, the mice were treated 3 times at daily intervals
with aerosolised OVA (1% w/v OVA in PBS) for 20 min [25].
24 h after the last treatment, the mice were either sacrificed and
analysed, or infected with 200 pfu/mouse of PVM.
Broncho-alveolar lavage (BAL)
Lungs were lavaged with 46800 ml PBS. The BAL fluid (BALF)
of the first lavage was used for quantification of cytokines. The
cells of the lavages from one mouse were pooled, counted, and
used for analysis or ex vivo stimulation.
Organs
After BAL, the right half of the lung was dissected, chopped in
pieces (,1 mm3) and digested for 1 h with 25 mg/ml Liberase DL
and 10 mg/ml DNase I (both Roche) in HBSS medium. The cell
suspension was treated with Gey’s solution to deplete erythrocytes,
washed, filtered through a 100 mm mesh, and used for flow
cytometry. The left half of the lung was snap-frozen and stored at
280uC until analysis.
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For the assessment of virus entry, lungs were instilled with
800 ml 4% formalin and kept in 4% formalin for 2 h at room
temperature. Afterwards, the lungs were washed with PBS,
tumbled for 24 h in 30% sucrose at 4uC, washed with PBS,
embedded in OCT, and kept at 4uC for another 24 h before
storage at 280uC.
Muc5ac and Muc5b expression
Lungs were snap frozen in liquid nitrogen and stored at 280uC.
For RNA extraction, the tissue was extracted with TriReagent
(Sigma), and the RNA was immediately reverse-transcribed with
SuperScript III (Invitrogen) using random hexamers as primers.
Quantitative PCR analysis was performed with a Lightcycler
(Roche), 18S RNA was used as internal standard. Primers used
were described earlier [26].
Cytokine analysis
Serum and BALF were stored at 280uC and analysed for IL-2,
IL-4, IL-5, IL-6, IL-10, IL-12p70 (IL-12), IL-13, IL-17, GM-CSF,
MIP-1a (CCL3), TNF-a, and IFN-c applying the Pro Cytokine
Assay with the Bio-Plex 200 System (both Bio-Rad). IFN-a was
determined with the Premium ELISA kit (eBioscience). To gauge
expression of IFN-b, Mx-1-competent mice harbouring a reporter
for IFN-b [27] were infected with S. mansoni. 12 weeks after
infection mice were sacrificed, and luciferase activity in lung tissue
was determined as described [27].
Endotoxin determination
Endotoxin levels in the serum of mice was determined by LAL
assay (QCL-1000, LONZA).
Flow cytometry
Single-cell suspensions of organs were treated with Gey’s
solution where appropriate, and washed with PBS/3% FCS.
The cells were preincubated with 20 mg anti-CD16/32 antibody
(clone 2.4G2), washed and stained with a combination of
fluorochrome-labelled monoclonal antibodies (all steps at 4uC).
Antibodies were from BD Biosciences {name [alternative name]
clone)} {TCRb (H57-597); CD4 (RM4-5 or GK1.5), CD5 ([Ly-1]
53–7.3), CD8 (53–6.7), CD11b (M1/70); CD11c (HL3), CD11c
(IM7), CD19 (1D3), Siglec F (E50-2440), NK1.1 (PK136), Ly6G
(1A8)}, eBioscience {I-Ab [MHC class II] AF6-120.1), H-2Kb
[MHC class I] AF6-88.5.5.3), CD3e (eBio500A2 or 145-2C11),
CD25 (PC61.5), CD27 (LG.7F9), CD45 (30-F11), CD90.2 (53–
2.1), F4/80 (BM8), Ly6C (HK1.4)}, and MD Bioproducts {T1-
ST2 (DJ8)}. Samples were processed on a LSR II flow cytometer
equipped for 10-parameter acquisition, and analysed with
TreeStar FlowJo software (version 9.5).
Characterization of ILCs and lung interstitial leukocytes
Lungs were digested as above and ILCs were prepared and
characterised as described [28] using the lineage markers CD11c,
CD3, B220, TCRb, CD5, CD27, NK1.1 and CD11b. Lineageneg
cells were considered ILCs when they were positive for the
markers CD45, CD90, CD25 and T1-ST2. Data shown are from
10, 8, 8, and 14 animals for control mice and from 10, 5, 6, and 4
animals for S. mansoni-infected mice at 0, 4, 7, and 10 days post
infection with PVM, respectively.
Histology
Sections of paraffin-embedded lungs were stained with H&E or
PAS and analysed for columnar cell hyperplasia, goblet cell
hyperplasia, atypica, degenerative changes, epithelial necrosis (for
the assessment of involvement of the bronchial mucosa), fibrosis,
and inflammation (for the assessment of interstitial disease).
Sections were scored blindly by one experienced observer. Scoring
was as follows: 0: normal; 1: minor; 2: intermediate; 3: markedly
increased pathology. Sections of OCT-embedded lungs were fixed
with 75% acetone/25% methanol, rehydrated with PBS, blocked
with anti-CD16/32 antibody (clone 2.4G2) and stained with rabbit
anti-PVM-antibody specific for the PVM-G protein [24]. They
were then washed, blocked with 5% goat serum and counter-
stained with goat Alexa555-conjugated anti-rabbit IgG (Invitro-
gen). The sections were embedded with ProLong Gold Antifade
containing DAPI (Invitrogen) and analysed on a Zeiss Imager Z1
at 106magnification (Zeiss, Plan-Apochromat, 0.17) with a Zeiss
AxioCam MRc. Data was acquired and processed with Zeiss
Axiovision software (release 4.8.2).
Statistics
Significant differences between two groups were estimated using
the unpaired t test with Welch correction for data with Gaussian
distribution (passed assumption method of Kolmogorov and
Smirnov), and the Mann-Whitney test for data with non-Gaussian
distribution. Significant differences between three groups were
estimated using two-way ANOVA with Bonferroni post-test.
Statistical relevance was indicated in the plots when significant
(p#0.05).
Results
Systemic cytokine response in C57BL/6 mice infected
with Schistosoma mansoni
In our studies we used a recent human isolate of S. mansoni,
which originated from Oman [22,29]. We first established the
optimal number of cercariae that caused chronic schistosomiasis in
C57Bl/6 mice (Fig. S1). 70–75 cercariae per mouse, infected at 9–
10 weeks of age, was considered optimal. Herewith a moderate,
chronic course of the disease was established that resembled
Henderson’s moderate splenomegaly syndrome (MSS) of mouse
schistosomiasis [30], and that allowed the study of secondary
infections in the chronic phase of the disease. Survival at 16 weeks
of age was more than 95% in a large group of animals that were
infected at different time points during this study. Serum cytokine
profiles were also established. As expected, a slight increase in
IFN-c levels was seen immediately after infection, indicative of
Th1-type immune responsiveness. Significant Th2-type respon-
siveness was seen from week 7 of infection onwards, after the onset
of oviposition, with IL-4 and IL-5 rising ahead of IL-13. Also, IL-
17 and IL-2 levels rose significantly after week 7. We found very
high systemic levels of the proinflammatory cytokines IFN-c, TNF-
a and GM-CSF after week 7, which challenges the idea of
mutually exclusive immune responses (Fig. 1). IL-10 showed small
peaks of activity at week 1, 4, and 8, which most likely reflected a
reaction to inflammatory processes after skin and lung passage of
the schistosomula, and egg passage into the gut [31].
These findings were not dependent on the Th1-prone mouse
strain C57BL/6J; in Th2-prone BALB/c mice we obtained similar
data, with the exception of GM-CSF, which did not increase (Fig.
S2).
We also analysed the ability of T cells from spleen and
mesenteric and pulmonary (mediastinal) lymph nodes to secrete
cytokines after polyclonal stimulation. The T cells produced high
levels of the Th1-type cytokines in vitro, also later in the infection
(Table S1). However, the increase of Th1 cytokines was less
profound than those of Th2 cytokines, in agreement with previous
reports [3].
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The high levels of serum IFN-c, but not those for TNF-a during
an infection with S. mansoni is dependent on ligands for TLR2
and/or TLR4, because in mice deficient for both TLRs serum
IFN-c was low throughout the infection (Fig. S3). In IL-12Rb2-
deficient mice neither a systemic IFN-c, nor a TNF-a response was
found (Fig. S3). We could not detect increased systemic levels of
endotoxin in mice that were infected with S. mansoni (Fig. S4).
We conclude that the immune response in C57BL/6 mice to a
chronic infection with S. mansoni is not polarised systemically.
High levels of the signature Th1 cytokine IFN-c are dependent on
TLR2 or 4 ligands, both TNF-a and IFN-c are dependent on
IL12Rb2.
Influence of chronic schistosomiasis on the lung
environment
The epithelial barrier layer of the lung reacts to environmental
stimuli with the production of alarmins like IL-33 and GM-CSF
[32–34], which attract dendritic cells. These cytokines also
stimulate innate lymphoid cells in the lung (ILCs [35,36]) to
produce IL-5 and IL-13, which create an intensely Th2-prone
environment, and to produce amphiregulin, which is important for
the integrity of the barrier layer [37]. We studied the steady state
conditions in the lung during the infection with S. mansoni
(Fig. 2). Analysis of the broncho-alveolar lavage fluid (BALF)
showed a transient increase in the Th1 cytokines IFN-c, TNF-a
and IL-12 at week 5 post infection. At this time point
schistosomula have passed through the lungs and establish in the
portal system. Thereafter, IFN-c fell below normal levels, while
TNF-a and IL-12 remained significantly increased throughout the
measurement period. The Th2 cytokines IL-5 and IL-13 increased
steadily from week 2 onwards; IL-4 was only increased late in
infection. IL-10 was increased around week 5 post infection, while
the stress cytokines IL-6 and MIP-1a were significantly increased
late in infection (Fig. 2A). Thus, also in the BALF we registered
concomitant, not mutually exclusive Th1 and Th2 immune
responses during the infection with S. mansoni.
We also analysed the cellular composition of the BALF
(Fig. 2B). Total cell numbers of eosinophils were increased
throughout the infection, with an early peak at week 2 of
infection. The number of CD4pos and CD8pos T cells and NK cells
were increased late in infection. In vitro TNF-asecretion by
CD4pos and CD8pos T cells was doubled late in infection (Fig. 2C).
The epithelial cell layer of the airway showed discrete signs of an
increased barrier function with mucus-producing goblet cell
hyperplasia, columnar cell hyperplasia, and light perivascular
and peribronchial infiltrates (Fig. 2D and Fig. S5A). Furthermore,
as signs of increased immunological alertness we saw a marked
increase in the expression of MHC class I and II on CD45pos
CD11bpos SiglecFneg interstitial lung cells (Fig. 3B, left panels). We
did not find an expansion of ILCs, rather we observed a relative
contraction of this cell population (Fig. S6A).
We conclude that in murine schistosomiasis a low-grade
inflammation is found in the lung with strong signs of an increased
barrier function.
Muc5a expression is increased in mice with chronic
schistosomiasis and is inhibited by depletion of TNF-a
Goblet cell hyperplasia can be induced, among others, by IL-13
[38] and TNF-a [39,40]. A hallmark of goblet cell hyperplasia is
the increased production of the gel-forming mucin Muc5ac
[41,42]. We determined Muc5ac mRNA levels in lungs of mice
infected with S. mansoni and in control mice. Muc5ac mRNA
levels were 106 times higher in infected mice compared to control
mice. As expected [42], only a moderate induction of the levels of
Muc5b was found in infected animals. We treated mice with
soluble TNF-receptor (Etanercept) [43] to explore the role of
TNF-a in the increased mucus production. After treatment of the
mice (starting at week 11 of infection), mRNA for Muc5ac
returned to baseline levels (Fig. 4). Thus, we conclude that TNF-a
is essential for pulmonary goblet cell hyperplasia in chronic
schistosomiasis.
Figure 1. Serum cytokine levels of C57BL/6J mice infected with
S. mansoni. Cytokine levels were determined at indicated time points
after infection. The data points represent means from 4–10 mice. Error
bars represent SEM. Significant differences between each time point
and control mice (day 0) are marked: *, p#0.05; **, p#0.01; ***, p#
0.001.
doi:10.1371/journal.pone.0112469.g001
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Coinfection of mice with chronic schistosomiasis with
influenza A virus
Increased production of Muc5ac has recently been shown to
protect from severe infection with influenza virus [44]. We
therefore tested the resistance of mice with chronic schistosomiasis
to a secondary infection with influenza. We first used influenza A
virus strain hvPR8, which is lethal to normal mice, even if they can
express the influenza virus resistance gene Mx1 [45]. However,
such mice are protected against hvPR8, if they are pretreated with
a single dose of type I IFN [20], because expression of Mx1 is
Figure 2. Immuno- and histopathology of lungs of C57BL/6J mice with schistosomiasis. A, BALF cytokine levels at indicated time points
after infection with S. mansoni. Data was cumulatively acquired from 6–9 mice in 3–4 experiments; B, Number of different cell types in the BALF of
mice with schistosomiasis, at indicated times after infection. Data points represent means of 13 (week 0 of infection), 4 (week 2), 7 (week 5), 9 (week 9)
and 14 mice (week 12) in 2–5 individual experiments. C, Potential of CD4pos and CD8pos BALF cells to produce IFN-c and TNF-a 4 hrs after stimulation
with PMA/Ionomycin/Brefeldin A, cells taken at the indicated time points after infection, left panels (FACS plots) show intracellular stainings, right
plots (bar graphs) show a quantitative rendition of the FACS data; data shown is representative for 3 individual experiments with 3 mice each. D,
Section of the lung (H&E staining) of a control animal (left) and a mouse 12 wks after infection with S. mansoni (right), insert shows goblet cell
hyperplasia (black arrows) and light cellular infiltrates (red arrow). Sections are representative for 3 mice each; Error bars represent SEM. Significant
differences between each time point and control mice (day 0) are marked: *, p#0.05; **, p#0.01; ***, p#0.001.
doi:10.1371/journal.pone.0112469.g002
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regulated by type I and type III interferons [46]. We found no
evidence for the presence of IFN-ain the BALF of mice infected
with S. mansoni (Fig. 5A). Further, IFN-b-reporter mice [27] that
were chronically infected with S. mansoni showed no evidence for
enhanced production of IFN-b in the lungs. However, IFN-b was
significantly enhanced in liver and to a lesser extent in the kidney
(Fig. S7). We infected Mx1-competent mice in the chronic phase
of schistosomiasis with 60 pfu of influenza A strain hvPR8. Mice
infected with S. mansoni, without pretreatment with IFN, were
significantly protected from a challenge with hvPR8, and they
survived longer when compared to non-infected (S. mansoni-free)
controls (Fig. 6A,B). When the challenge dose of influenza virus
was increased to 200 pfu per animal, animals with chronic
schistosomiasis were still relatively protected and survived longer
than control animals (Fig. 6C,D). From these experiments we
conclude that infection with S. mansoni offers a relative, but
significant protection from influenza virus, which is independent of
IFN production.
To gauge the role of Muc5ac, we treated Mx1-deficient mice
that were infected S. mansoni 10 weeks previously with Etanercept
or PBS 3 and 1 day before, and also 1 and 3 days after infection
with influenza A virus strain PR8 (2000 pfu/mouse). Control mice
which were not infected with S. mansoni were treated similarly. As
expected, control mice were not protected from infection
(Fig. 6E,F). However, mice with chronic schistosomiasis were
significantly protected with less weight loss and enhanced survival.
Figure 3. Immuno- and histopathology of lungs of C57BL/6J mice with a coinfection of S. mansoni and PVM. A, Section of the lung (H&E
staining) of control animals (left) and mice 12 wks after infection with S. mansoni (right), at indicated time points after infection with PVM (200 pfu/
mouse). B, FACS profiles of the expression of MHC class I and II antigens on interstitial CD45pos CD11bpos SiglecFneg lung cells of mice with chronic
schistosomiasis (12 weeks) and control animals, before and 4 days after challenge with PVM, shaded grey: control mice, black line: mice with
schistosomiasis. The data shown are pooled samples from 3 mice and is representative for 9 mice in 3 individual experiments; C, Combined
histopathological score of mice treated as described in panel A, at the indicated time points after challenge with PVM. Bars represent the mean
results from 2–3 mice per group. Scoring: 0: normal; 1: minor; 2: intermediate; 3: markedly increased pathology; Error bars represent SEM. Significant
differences are marked: *, p#0.05; **, p#0.01; ***, p#0.001.
doi:10.1371/journal.pone.0112469.g003
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Treatment with Etanercept abrogated protection, which indicates
that the reduced virulence of influenza A virus in mice with
chronic schistosomiasis is mediated by a TNF-a-induced goblet
cell hyperplasia and enhanced Muc5ac synthesis.
Coinfection of mice with chronic schistosomiasis with
pneumonia virus of mice (PVM)
We also performed coinfection experiments with S. mansoni-
infected mice and the respiratory virus PVM to validate our
findings with a second pneumoviral infection. 12 weeks after
infection with S. mansoni, mice were challenged intranasally with
a sublethal dose (200 pfu/mouse) of PVM. C57BL/6 mice without
S. mansoni showed, as expected [47], signs of disease and a
significant loss of weight 8–9 days after infection, followed by a
recovery. In contrast, mice infected with S. mansoni 12 weeks
before viral challenge did not show additional signs of disease and
did not lose weight (Fig. 7A). Viral challenge shortly after infection
with S. mansoni did not cause protection (Fig. 7B), in fact,
reproducible protection was only found after week 8 of infection
(data not shown). Whereas viral challenge with 2000 pfu/mouse
was lethal in control mice, mice with chronic (12 weeks)
schistosomiasis survived this type of challenge, but they did show
signs of disease (Fig. 7C,D). Sublethally infected T cell-deficient
mice fail to clear the virus, but they are able to exert some virus
control, and the virus load can stay constant over weeks without
extensive disease or weight loss [47]. The reported dominant Th2
response and immune regulatory activity in the chronic phase of
schistosomiasis prompted the question, whether mice with
schistosomiasis controlled or cleared the virus. Fig. 7E shows that
mice with schistosomiasis carried a significantly reduced (p#0.01)
viral burden at day 7 post PVM infection and were able to clear
the infection. Immunohistochemical staining of the lungs corrob-
orated this finding (Fig. 7F).
Before viral challenge we found increased levels of TNF-a, IL-5,
and IL-13 in the BALF of mice with chronic schistosomiasis
compared to healthy controls (Fig. 2A, week 12 and Fig. 5A, day
0). At day 4 after viral challenge we found significantly higher levels
of TNF-a, IL-5 and IL-13 in mice with chronic schistosomiasis,
whereas at day 7 control animals had significantly higher levels of
IFN-c and IL-6, but lower levels of IL-13. At day 10 after
challenge, the titers of TNF-a, IL-5 and IL-13 remained high in
Schistosoma-infected mice and were significantly increased com-
pared to control animals, all of which showed falling titers for all
measured cytokines. As expected [48], IFN-a, a type I interferon,
was markedly increased at day 7 after viral challenge in the BALF
of control animals, but was not increased in Schistosoma-infected
mice (Fig. 5A).
CD4pos T cells, CD8pos T cells, NK cells, and eosinophils were
present in significantly higher numbers at all times after viral
challenge in the BALF of Schistosoma-infected mice when
compared to control animals, with the exception of day 7 and
10, where we found highly increased numbers of NK cells in
control mice (Fig. 5B). At day 4 after viral challenge, expression of
MHC class I and II antigens on interstitial CD45pos CD11bpos
SiglecFneg lung cells was only marginally increased in control mice,
while the expression stayed high in mice with chronic schistoso-
miasis (Fig. 3B).
The protective effect of bilharzia on subsequent viral challenge
was not found in mice that were infected 12 weeks prior with
single-sex cercariae (Fig. S8), which indicates that the eggs - rather
than the worm itself - induce protection.
Histopathology in mice infected with PVM
We scored the extent of histopathology of the bronchial
mucosae and of the lung parenchyma before and after challenge
with PVM (Fig. 3A). The combined score is shown in Fig. 3C
(scores for the individual parameters are shown in Fig. S5, B–F).
Early in the infection with PVM (day 0 (Fig. 2D) and day 4
(Fig. 3A and S5B)), mice with chronic schistosomiasis had marked
goblet cell hyperplasia, which disappeared later on. At day 4 and 7
after viral challenge, the combined score was significantly lower in
Schistosoma-infected mice when compared to controls.
Inflammatory processes with a strong Th2 component
can protect from viral attack
Another factor that can lead to increased Muc5ac production is
an increased level of IL-13 in the lungs [38], as is found in
pulmonary inflammatory processes, in particular in those with a
strong Th2 component. Indeed, in a model of allergic airway
inflammation [25] we saw type II inflammatory responses similar
to those in the lungs of mice with schistosomiasis, but more
pronounced. Levels of IL-5 in serum were high (Fig. 8A). In BALF
high levels of IL-4, IL-5 and IL-13 were found (Fig. 8B). We found
increased numbers of CD4pos and CD8pos T cells, NK cells, and
eosinophils in BALF (Fig. 8C). The expression of MHC class I, but
not of MHC class II antigens on CD45pos CD11bpos SiglecFneg
interstitial lung cells was increased (Fig. 8D). When challenged
with 200 pfu/mouse PVM, ovalbumin-immunised and -chal-
lenged mice were protected from loss of weight and signs of disease
(Fig. 8E). At day 7 after viral challenge these mice had significantly
lower viral titres than the control mice (Fig. 8F).
Discussion
In this work we studied the immunological influence of murine
schistosomiasis on a subsequent challenge with a respiratory virus.
Mice that are chronically infected with an human Omani isolate of
S. mansoni are relatively, but significantly protected from a viral
respiratory challenge with low doses of influenza A virus or
pneumonia virus of mice (PVM), and they survived challenges
with normally lethal doses. The protection is caused by
Figure 4. Muc5ac and Muc5b expression in the lungs of mice
with chronic schistosomiasis before and after treatment with
Etanercept. At 11 week of infection with S. mansoni, mice were
treated 3 times, every other day, with 4 mg/kg body weight,
intraperitoneally. Lungs were taken at day 6 of treatment. Error bars
represent SEM. Significant differences between each time point and
control mice (day 0) are marked: *, p#0.05.
doi:10.1371/journal.pone.0112469.g004
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TNF-a-mediated goblet cell hyperplasia and concomitant Muc5ac
production in the lungs of S. mansoni-infected mice.
Th1- besides Th2- and Th17-mediated immunity in
murine schistosomiasis
S. mansoni is thought to induce primarily Th2 immune
responses in the chronic, egg-depositing stage of the disease
[2,10]. Indeed, Schistosoma eggs themselves are considered
important drivers of Th2 responses, through principles secreted
by them: IPSE-alpha-1 [49] and omega-1 [50,51]. Th2 responses
are thought to inhibit Th1 responses, either by direct inhibition or
by a relative deficiency for the appropriate inducing cytokine. A
careful analysis of the systemic (serum) cytokine levels in mice
chronically infected with the Omani isolate revealed that type 1
(IFN-c, TNF-a, GM-CSF), type 2 (IL-5, IL-13, to a lesser degree
IL-4), and type 17 (IL-17) cytokines coexisted throughout the
infection. The cytokines rose to high levels from week 8 of
infection onwards. When probed for potency, CD4pos and CD8pos
T cells from the spleen and mesenteric lymph nodes produced
high levels of IFN-c and TNF-a, besides IL-4, IL-13 and IL-17.
The increase in production of Th2 cytokines was percentually
higher than those of Th1 cytokines. IL-4 and IL-13 are
Figure 5. Analysis of BALF and lung tissue of C57BL/6J mice with schistosomiasis and control mice before (day 0) and at indicated
time points after infection with PVM (200 pfu/mouse). Filled columns: mice with schistosomiasis, empty columns: control mice. A, Cytokine
levels. Bars represent data from 7–15 mice in 3–5 individual experiments; B, Cell counts for different cell types (CD4pos T cells, CD8pos T cells,
eosinophils and NK cells) in the BALF of mice that were infected only with PVM (empty columns), or with S. mansoni and challenged 12 wks later with
PVM (filled columns) and control mice (empty columns at day 0). Data are from 9–15 mice in 4–5 individual experiments. Error bars represent SEM.
Significant differences are marked: *, p#0.05; **, p#0.01; ***, p#0.001.
doi:10.1371/journal.pone.0112469.g005
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indispensible in the gut to initiate tissue repair mechanisms [11]
and to expel worm eggs [52], and IL-17 is necessary for protection
from bacterial attack through the battered gut wall [53,54]. TNF-
a, IL-13 and IL-17 can all induce mucin production, both in the
intestines and in the airways. Mucins play an important role in
worm expulsion, Muc5ac can expell and harm certain nematodes
[55]. Remarkably, for intestinal goblet cell hyperplasia in
schistosomiasis signalling by IL-4/IL-13 is dispensible [56].
Thelper cell polarisation
The notion that Th1 or Th2 polarisation occurs in a systemic
fashion was strongly influenced by early studies on leishmaniasis.
These showed an exclusive responsiveness and a different
immunity, depending on the strain of mice (C57BL/6 and
BALB/c) [57]. We compared C57BL/6 and BALB/c mice in
their systemic response to S. mansoni and could not find
fundamental differences. Can we explain previous, discordant
results of other groups? First, some reports are compatible with our
results [58], and in a meta-analysis, Yu et al. [59] found
significantly increased TNF-a and IL-4 levels in human patients
with schistosomiasis. Second, we did not infect with the commonly
used Puerto Rican strain of S. mansoni. However, the Omani
strain caused a disease that resembled the moderate splenomegaly
syndrome (MSS) of mice [30], with very few eggs being dispersed
Figure 6. Coinfection experiments with S. mansoni-infected C57BL/6J mice and Influenza A virus. A–D: Analysis of C57BL/6 mice carrying
functional Mx1 alleles (B6.A2G-Mx1) after infection with S. mansoni and influenza A virus (strain hvPR8). E–F: Analysis of wild-type, MX-1-deficient
C57BL/6 mice after infection with S. mansoni and influenza A virus (strain PR8). A, Relative weight loss of mice with chronic schistosomiasis (10 wks;
red) and control animals (black) at indicated times after challenge with 60 pfu/mouse of hvPR8. Some control mice received 50.000 U IFN-a, given
one day before challenge with hvPR8 (green). Data points were cumulatively acquired from 3–4 mice in each group in one experiment. Error bars
represent SEM; B, Survival curves of mice in Fig. 6A. C, Relative weight loss of mice with chronic schistosomiasis (10 wks, red) and control animals
(black) at indicated time points after challenge with 200 pfu/mouse of hvPR8. Some control mice received 50.000 U IFN-a, given one day before
challenge with hvPR8 (green). Data points were cumulatively acquired from 7 mice in each group in one experiment; D, Survival curves of mice in Fig.
6C; E, Relative weight loss of mice with chronic schistosomiasis (10 wks; red, treated with Etanercept, blue, not treated, black, control animals treated
with Etanercept) at indicated time points after challenge with 2000 pfu/mouse. Data points were cumulatively acquired from 7, 5 and 7 mice in each
group, respectively, in one experiment; F, Survival curves of mice in Fig. 6E; Error bars represent SEM. Significant differences are marked: *, p#0.05; **,
p#0.01; ***, p#0.001, nd: below detection limit of 10 pfu.
doi:10.1371/journal.pone.0112469.g006
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Figure 7. Coinfection experiments with S. mansoni-infected C57BL/6J mice and pneumonia virus of mice (PVM). A, Relative weight loss
of mice with chronic schistosomiasis (12 wks) and control animals at indicated times after a sublethal dose (200 pfu/mouse) of PVM. Data are from
30–38 mice in 7–8 experiments. B, Relative weight loss of mice at the indicated time points after challenge with 200 pfu/mouse of PVM, at 1 and 4
weeks after infection with S. mansoni. The data are cumulative from 15 (week 1), 6 (week 4), and 52 (control) mice representative of 3, 1 and 12
experiments, respectively; C, Relative weight loss of mice with chronic schistosomiasis (12 weeks) and control animals at indicated time points after a
lethal dose (2000 pfu/mouse) of PVM. The data are cumulative from 10 mice in 2 individual experiments; D, Survival curves of mice in Fig. 7C; E, Viral
load, expressed as pfu, in the right lobes of the lungs of mice, treated as described in Fig. 7A, at day 4, 7 and 10 after challenge with PVM. Bars
represent data from 9–15 mice in 2–4 individual experiments; F, Lungs of mice as described in Fig. 7A were taken at day 4, fixed with
paraformaldehyde and stained with an antibody directed against the G-protein of PVM. The infected areas are enclosed with dashed lines. Images are
representative for 6 sections from 3 individual mice per group; Error bars represent SEM. Significant differences between groups at one time point are
marked: *, p#0.05; **, p#0.01; ***, p#0.001, nd: below detection limit.
doi:10.1371/journal.pone.0112469.g007
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to the lungs. Third, in some studies mice were treated with
antibiotics, which are known to significantly affect the microbiome
and therewith the immune response [17,18,60]. We did not find
evidence for a systemic bacterial spread or LPS in the blood of
infected mice [61]. Fourth, in many experiments, mice were not
followed beyond week 8, only 2 weeks after the onset of oviposition
Fifth, the majority of conclusions relied on experiments in which
ex vivo production of cytokines by polyclonally stimulated T cells
was measured [3,62]. In this approach the potential activity rather
than actual activity of regional T cells is gauged [63]. We strongly
support the idea, that regional immune cells can exert exclusive
regional functions, for instance the production of Th2 cytokines in
the gut. These facilitate egg transition through the gut and limit
inflammation in the gut [60]. Finally, the concept of mutually
exclusive responses slowly becomes cracks: recent studies point
towards a more plastic view on the response [64,65], and cell fate
seems to be fixed rather early in the differentiation pathway of a T
cell. In this concept, specifically responsive cells can be called upon
later, when demand is present [66,67]. Early systemic Th1
responses in S. mansoni could function as a stabilisator of the
enhancer ‘‘landscape’’, allowing continuous access to a Th1-prone
cell pool [68]. Indeed, several groups found evidence for dual or
hybrid types of helper T cells [69–71]. We therefore argue that our
model of murine schistosomiasis resembles early infection in
human, in which, like in our model, Th1, Th2 and Th17 cells
coexist.
Figure 8. Resistance of C57BL/6 mice with inflammatory airway processes to challenge with PVM. A, B, Cytokine levels in the serum (A)
and BALF (B) 24 h after the last of 3 consecutive days of aerosolised OVA of OVA-immunised mice (C57BL/6J) compared to mice infected with S.
mansoni and control mice. The data shown are pooled from 4–8 mice in 3 individual experiments; C, Number of cells of various cell types in the BALF
of mice 24 h after the last of 3 consecutive days of treatment with aerosolised OVA of OVA-immunised mice (C57BL/6J) compared to mice infected
with S. mansoni and control mice. The data are from 10–14 mice in 3–5 individual (depending on the time point) experiments; D, FACS profiles of the
expression of MHC class I and II antigens on interstitial CD45pos CD11bpos SiglecFneg lung cells of C57BL/6J mice 24 h after the last of 3 consecutive
days of aerosolised OVA challenge of OVA-immunised mice (thick lines) and control mice (shaded grey). Data shown is representative for 6 mice from
2 experiments; E, Relative weight loss of OVA-immunised mice (C57BL/6J) challenged with a sublethal dose (200 pfu/mouse) of PVM 24 h after the
last of 3 consecutive days of aerosolised OVA and control mice at the indicated times after challenge. The data are cumulative from 10–16 mice in 3
individual experiments. The controls were obtained separately and are the same as in Fig. 7A. F, Viral load, expressed as pfu, in the right lobes of the
lungs of mice, treated as described in Fig. 8E, at day 4 and 7 after challenge with PVM. The controls were obtained separately and are the same as in
Fig. 7E. The data from OVA-immunised mice are derived from 2 and 3 mice (day 4 and 7, respectively). Error bars represent SEM. nd: not detectable.
Significant differences are marked: *, p#0.05; **, p#0.01; ***, p#0.001.
doi:10.1371/journal.pone.0112469.g008
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The role of TNF-a in schistosomiasis
High levels of TNF-a and IFN-c are often implied in the
pathogenesis of a severe form of human schistosomiasis, the
hepato-splenic form [72], which could resemble Henderson’s
hypersplenomegaly syndrome (HSS). As outlined, we do not find
evidence for HSS in our model. Also in the mild form, hepatic
involvement in mice is more pronounced than in benign cases of
human schistosomiasis. Also in MSS increased levels of TNF-a are
found in liver tissue [73]. In mice both protective and deleterious
effects have been described for TNF-a, together with evidence that
granuloma-induced TNF production is necessary for the matura-
tion of the adult worms [74,75].
Pulmonary milieu in murine schistosomiasis
In chronic murine schistosomiasis the lungs show low-grade
inflammatory processes, with goblet cell hyperplasia and increased
production of the gel-forming mucin Muc5ac (see Fig. S9 for a
graphical summary of our data). Early in the infection Th1
cytokines were found in BALF, they stayed high with the exception
of IFN-c. Th2 cytokines also rose early, with the exception of IL-4.
Pathology in our model was less pronounced than in that
described by Crosby et al. [58], which could well be explained
by the lower number of parasite eggs found in the lungs of our
mice. The sustained high levels of IL-13 and IL-5 without a joined
increase of IL-4 suggests that they were not derived from Th2-type
helper cells, but rather from ILC2-type cells [76,77]. However, we
saw a relative decrease in number of ILCs during the course of
schistosomiasis, likely arguing against an activated state of the
ILCs [37]. Instead, our results indicate that sustained high levels of
systemic TNF-a were primarily responsible for the goblet cell
hyperplasia.
Coinfection studies with S. mansoni and influenza virus
or PVM
In this Schistosoma-moulded milieu respiratory viruses do not
spread as easily as in a healthy environment. PMV did not expand
as rapidly and was cleared with a lower expenditure of CD8pos
cytotoxic T cells, and therefore with less airway inflammation and
involvement. As a consequence, a lower combined histopathology
score was found. The virulent influenza virus strain hvPR8 is lethal
to normal (Mx-competent) mice, unless they are pretreated with
type-I or type III interferons, which induce the indispensible Mx
protein. Mice with chronic schistosomiasis were to a certain extent
resistant to strain hvPR8, indicating that the infection with S.
mansoni had either induced the production of type I or type III
interferons or that other protective mechanisms, like the produc-
tion of Muc5ac [44], were active. We were unable to detect
significant amounts of IFN-a by ELISA in mice with schistoso-
miasis, and reporter mice for IFN-b did not show any significant
involvement of IFN-b. Therefore, we conclude that type I
interferons did not play a significant role in the observed
protection, although we cannot completely exclude the involve-
ment of type III interferons [78]. High levels of isolated production
of Muc5ac in the lung, as found in Muc5ac-transgenic mice,
protects from infection with influenza A virus [44]. In these studies
Muc5ac production was increased by a factor of 20, in our studies,
mice with chronic schistosomiasis had a ten-fold induction of
Muc5ac. Treatment of the mice with Etanercept revealed that
upstream TNF-a was responsible for this induction. Indeed, Mx1-
deficient mice with chronic schistosomiasis were relatively, but not
absolutely protected from an infection with influenza A virus, and
the protection was lost after treatment with Etanercept.
TNF-a does not seem to affect viral replication in primary
infections [47,79,80]. However, TNF has a significant effect on
immunopathology: it negatively regulates the extent of pathology
[79], or increases pathology [80], depending on virus strain and
study design. Therefore we favour the notion that was put forward
by Ehre et al. [44]: mucus alone is sufficient to sequester virus and
reduce viral entry into the lung cells. Less cytotoxic T cells were
needed for viral control, which resulted in reduced tissue damage.
The role of TNF-a in Muc5ac expression and goblet cell
hyperplasia
TNF-a has a direct influence on Muc5ac transcription via the
NF-kB pathway, and it induces expression of the EGFR [40]. NF-
kB further modulates IL-13Ra1-signalling [81]. Both the IL-
13Ra1 and the EGFR are essential in the development of goblet
cell hyperplasia. It is debated, whether these factors work in
parallel or whether engagement of the EGFR is making the goblet
cell receptive for consecutive IL-13 signalling [82]. We saw that
short-time treatment of mice with Etanercept, i.e. neutralising
TNF-a in the continuing presence of IL-13, inhibited Muc5ac
expression and interfered with protection to viral challenge. This
suggests a role for TNF-a that is independent of IL-13. Indeed, it
was clearly shown that the mere transgenic expression of Muc5ac,
without the involvement of (IL-13-driven) inflammatory responses,
is protective in influenza infections [44].
Factors influencing protection
The increased resistance to viral attack and the increased
immunological ‘‘alertness’’ in the lungs of mice with schistosomi-
asis is not dependent on worm passage through the lungs, because
infections with single-sex cercariae did not protect from viral
attack. Protection is reliably found after week eight of infection,
thus after the onset of oviposition. This coincides with the first
deposition of eggs in the liver and the subsequent granulomatous
reaction, but more importantly, also the passage of the eggs
through the intestinal wall. This causes considerable damage, leads
to inflammation, the secretion of high amounts of IL-17, and a
noticeable change in the stool constitution with first some, later
more - and also bloody - mucoid stool. Conditions in the gut of
mice with schistosomiasis are therefore very different from normal.
Already under normal conditions, bacterial products can enter the
body, enhance systemic innate immunity [36], and exert
considerable influence also in distant compartments like the lung.
Effective immunity to influenza virus is dependent on the existing
microbiome [17,18], with bacterial products of gram-positive
bacteria and certain TLR-ligands (TLR2,-3,-4 or -9) as active
principle, even when rectally applied [17]. Abt et al. showed that
interferon-induced genes were responsible for this kind of
protection [18]. We could show, that systemic IFN-c responses
were absent in TLR2,4-double-deficient mice with schistosomiasis.
In IL-12Rb2-deficient mice both IFN-c and TNF-awere absent,
pointing to an IL-12/IFN-c axis in protection in mice with
schistosomiasis.
Allergic inflammation and viral infections
We then asked whether pulmonary inflammatory processes in
general could lead to protection. We found that in a mouse model
of asthma mice were protected from viral attack by PVM, to a
similar degree as found in mice with schistosomiasis. Indeed,
conditions in the lung were to a large degree comparable, with a
strong Th2 component in the inflammation. These results were
not unexpected, Th2 cytokines, in particular IL-13, are potent
inducers of goblet cell hyperplasia and Muc5ac production and
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thus protective in viral attacks. Remarkably, in the recent
pandemic influenza (H1N1) infection, asthma was independently
associated with a lower risk of dying during hospitalisation [83].
We interpret these results as a reflection of an increased immune
alertness, with goblet cell hyperplasia and Muc5ac production.
This response will initially protect the host from pneumotropic
viruses, but in chronic conditions it may be detrimental for the
host because of ensuing, debilitating chronic inflammatory
processes like COPD [84].
Other helminths will exert other effects
We do not think that our findings can be transferred to all
helminth infections. In infections in which the parasite deploys
systemic immunosuppression, as does for instance Heligmoso-
moides polygyrus [85,86], or induces only a weak Th1 response,
the outcome can be different. Indeed, two recent articles
supported this notion. In a murine model, infection with H.
polygyrus and S. mansoni eggs (a complete infectious cycle was not
tested) could reactivate the mouse c-herpes virus MHV68 in vivo,
via an IL-4- and Stat6-dependent pathway[87]. In a second study,
Trichinella spiralis and H polygyrus both could inhibit specific T-
cell responses to murine norovirus, or to influenza virus (only
tested with T. spiralis). Immune modulation was shown to be
dependent on a Stat6-dependent alternative activation of macro-
phages and their secreted product Ym1 [88]. In both cases, Th2-
type immune responses are induced, without previous Th1-type
immunity. Unfortunately, no data were provided for the lung
environment.
In schistosomiasis, we did not find evidence for a generalised
immune suppression. The similarity of S. mansoni-induced and
allergen-induced pulmonary inflammation rather predicts a more
severe course, when allergy and schistosomiasis coexist. The
immune regulatory activity of T regulatory cells and IL-10 is
therefore most likely secondary to inflammation and antigen-
specific [54]. Remarkably, in schistosomiasis, a disease with at least
200 million people a year needing treatment, little tenable
information is available regarding comorbidities. Of course, many
variables can influence the outcome of coinfections, as discussed
extensively by Abruzzi and Fried [6].
In conclusion, our results shed a new light both on the biology of
schistosomiasis and the immune response to the parasite. Contrary
to previous reports, we do not find the immune responses to be
polarised systemically, but they reflect local need for defence.
From an evolutionary point of view, the parasite would initially
benefit from an increased barrier function towards common
pathogens like respiratory tract viruses.
Supporting Information
Figure S1 Determination of the optimal cercarial dose
of S. mansoni that leads to a chronic disease. A, five
C57BL/6J mice were exposed to different number of cercariae
and analysed 12 weeks after infection for worm burden (D), worm
pairs (X), infection rate (#) and weight of liver (&) and spleen
(%). B, total number of eggs/liver 12 weeks after infection, relative
to the cercarial dose. Data points represent mean data from 3–7
mice in one experiment. Error bars represent SEM. Grey zones
indicate the optimal cercarial dose we have used in further
experiments to obtain a chronic course of the disease.
(TIF)
Figure S2 Serum cytokine levels in BALB/cJ mice at
indicated time points after infection with S. mansoni. A,
signature Th1 cytokines IFN-c and TNF-a and B, D, signature
Th2 cytokines IL-5, IL-13 and IL-4 were measured, as well as C,
D, IL-6, IL-17 and IL-2. The data points represent means from 2–
7 mice. Error bars represent SEM. Significant differences between
each time point and control mice (day 0) are marked: *, p#0.05;
**, p#0.01; ***, p#0.001.
(TIF)
Figure S3 Serum IFN-c(A) and TNF-a(B) levels in
C57BL/6J (black line), TLR2–/–/4–/– (green line) and
IL-12Rb2–/– (blue dotted line) mice at indicated time
points after infection with S. mansoni. Error bars represent
SEM. Significant differences between each time point and control
mice (day 0) are marked: *, p#0.05; **, p#0.01; ***, p#0.001.
(TIF)
Figure S4 Serum endotoxin levels in C57BL/6 mice at
indicated time points after infection with S. mansoni.
Serum endotoxin levels were determined by LAL assay. The data
points represent means from 11, 4 and 12 mice at week 0, 5, and
12, respectively. Error bars represent SEM. ANOVA analysis
(Kruskall-Wallis): p = 0.0488.
(TIF)
Figure S5 Histo-pathological scores of the lungs of
C57BL/6Jmice with chronic schistosomiasis. A, basal values
at 12 weeks after infection with S. mansoni; B–F, scores of mice with
schistosomiasis (12 wks; black) and control animals (white) at
indicated times after a sublethal dose (200 pfu/mouse) of PVM.
Columns represent mean results from 2–3 mice per group. Error bars
represent SEM. Scoring: 0: normal; 1: minor; 2: intermediate; 3:
markedly increased. Absence of bars represents normal (0) scoring.
(TIF)
Figure S6 Analysis of ILCs in the lungs of control mice
and at indicated time points after infection with S.
mansoni. ILCs were prepared from the right lobes of the lungs.
A, gating strategy. Lin: Lineage markers. The plots are
representative for n = 10 (control), 4 (week 2), 2 (week 5), 4 (week
9) and 10 (week 12) mice. B, total number of cells that are Lin-
negative and positive for the markers CD25, CD90 and T1-ST2.
Significant differences between groups are marked: *, p#0.05; **,
p#0.01; ***, p#0.001.
(TIF)
Figure S7 Type I interferon levels in mice infected with
S. mansoni at week 12 of infection. A, IFN-a levels in BALF;
B, IFN-b levels in indicated organs (RLU: relative luciferase units)
Error bars represent SEM. Significant differences between each
time point and control mice (day 0) are marked: *, p#0.05; ***,
p#0.001.
(TIF)
Figure S8 Coinfection experiments with S. mansoni-
infected mice and pneumonia virus of mice (PVM). Mice
were i.n. challenged at day 0 with 200 pfu of virus. Relative weight
loss of C57BL/6J mice infected with 100 cercariae of a single sex
(cercariae obtained from snails infected with only 1 miracidium)
(12 wks) and control animals at indicated times. Data are pooled
from 13 mice in 2 experiments. Error bars represent SEM.
Significant differences between data points from normal and single
sex infection with S. mansoni are marked: *, p#0.05; **, p#0.01.
(TIF)
Figure S9 Graphical summary. Representation of pulmo-
nary conditions. Upper left: normal condition. Upper right:
chronic schistosomiasis. Lower left: infection with a respiratory
virus. Lower right: secondary infection with a respiratory virus in
chronic schistosomiasis.
(TIF)
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Table S1 Ex vivo stimulation of cells. Pulmonary lymph
nodes (pLN), spleens and mesenteric lymph nodes (mLN) were
taken from mice on the C57BL/6J background and single cell
suspensions were prepared. At week 0 not enough cells could be
prepared from the pLN to perform in vitro stimulation. Cells were
then incubated for 4 h in complete medium containing phorbol
12-myristate 13-acetate (PMA, 20 ng/ml), Ionomycin (500 ng/ml)
and Brefeldin A (1 mg/ml). Cells were stained extracellularly and,
after fixation, stained intracellularly with fluorochrome-labelled
anti-TNF-a (MP6-XT22), anti-IFN-c (XMG1.2), anti-IL-4
(11B11) and anti IL-13 (eBio13A), using the IntraSure fixation
and permeabilisation kit (all from BD Biosciences, except for anti
IL-13, which was from eBioscience). The percentage of cells
positive for the indicated cytokine is given.
(TIF)
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